Key Features
-
Recurrent and progressive candidal infections of skin, nails and mucosae.
-
May be associated with autoimmune endo-crinopathies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agostoni A, Aygoren-Pursun E, Binkley KE et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51–S131
Bauer TR, Schwartz BR, Liles WC et al (1998) Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1. Blood 91:1520–1526
Bracho FA (2005) Hereditary angioedema. Curr Opin Hematol 12:493–498
Buckley RH (2004) The multiple causes of human SCID. J Clin Invest 114:1409–1411
Buoni S, Zannolli R, Sorrentino L et al (2006) Betamethasone and improvement of neurological symptoms in ataxia-telangiectasia. Arch Neurol 63:1479–1482
Collins SM, Dominguez M, Ilmarinen T et al (2006) Dermatological manifestations of autoimmune polyendo-crinopathy-candidiasis-ectodermal dystrophy syndrome. Br J Dermatol 154:1088–1093
Conley ME, Saragoussi D, Notarangelo L et al (2003) An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 109:272–277
DeWitt CA, Bishop AB, Buescher LS et al (2006) Hyperimmunoglobulin E syndrome: two cases and a review of the literature. J Am Acad Dermatol 54:855–865
Dupre L, Marangoni F, Scaramuzza S et al (2006) Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WA S promoter/cDNA-containing lentiviral vector and nonlethal irradiation. Hum Gene Ther 17:303–313
Eapen M, Delaat CA, Baker KS et al (2007) Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 39:411–415
Eberting CL, Davis J, Puck JM et al (2004) Dermatitis and the newborn rash of hyper-IgE syndrome. Arch Dermatol 140:1119–1125
Gallin JI, Alling DW, Malech HL et al (2003) Itraconazole to prevent fungal infections in chronic granulomatous disease. N Engl J Med 348:2416–2422
Grimbacher B, Holland SM, Puck JM (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250
Gungor T, Halter J, Klink A et al (2005) Successful low tox-icity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients. Transplantation 79:1596–1606
Jayasinghe M, Schmidt S, Walker B et al (2006) Successful treatment of azole-resistant chronic mucocutaneous candi-dosis with caspofungin. Acta Derm Venereol 86:563–564
Lai CH, Chun HH, Nahas SA et al (2004) Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci U S A 101:15676–15681
Malech HL, Hickstein DD (2007) Genetics, biology and clinical management of myeloid cell primary immune deficiencies: chronic granulomatous disease and leukocyte adhesion deficiency. Curr Opin Hematol 14:29–36
Marciano BE, Wesley R, De Carlo ES et al (2004) Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin Infect Dis 39:692–699
Namazi MR, Handjani F (2006) Lithium: a potential treatment for hyper-IgE syndrome. Med Hypotheses 66:1047
Orange JS, Levy O, Geha RS (2005) Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 203:21–37
Orange JS, Stone KD, Turvey SE et al (2004) The Wiskott-Aldrich syndrome. Cell Mol Life Sci 61:2361–2385
Peces R (2002) Partial lipodystrophy in two HLA identical sisters with hypocomplementemia and nephropathy. Nefrologia 22:564–569
Polizzi B, Origgi L, Zuccaro G et al (1996) Case report: successful treatment with cimetidine and zinc sulphate in chronic mucocutaneous candidiasis. Am J Med Sci 311: 189–190
Puck JM, Malech HL (2006) Gene therapy for immune disorders: good news tempered by bad news. J Allergy Clin Immunol 117:865–869
Puel A, Picard C, Ku CL et al (2004) Inherited disorders of NF-kappaB-mediated immunity in man. Curr Opin Immunol 16:34–41
Reeves EP, Lu H, Jacobs HL et al (2002) Killing activity of neutrophils is mediated through activation of proteases by K + flux. Nature 416:291–297
Ridanpaa M, van Eenennaam H, Pelin K et al (2001) Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 104:195–203
Rosenzweig SD, Holland SM (2004) Phagocyte immunode-ficiencies and their infections. J Allergy Clin Immunol 113:620–626
Sanal O, Gocmen A, Tezcan I et al (1990) Hyper-IgE syndrome: a case report. Turk J Pediatr 32:273–278
Sastry J, Kakakios A, Tugwell H et al (2006) Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection. Pediatr Blood Cancer 47: 327–329
Schurman SH, Candotti F (2003) Autoimmunity in Wiskott-Aldrich syndrome. Curr Opin Rheumatol 15:446–453
Shackelford RE, Manuszak RP, Johnson CD et al (2004) Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair (Amst) 3: 1263–1272
Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 3:155–168
Stinchcombe J, Bossi G, Griffiths GM (2004) Linking albinism and immunity: the secrets of secretory lysosomes. Science 305:55–59
Suzuki T, Imamura A (2005) A case of chronic mucocutane-ous candidasis cured with micafungin. Kansenshogaku Zasshi 79:143–148
Wang J, Cunningham-Rundles C (2005) Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). J Autoimmun 25: 57–62
Weiler CR, Bankers-Fulbright JL (2005) Common variable immunodeficiency: test indications and interpretations. Mayo Clin Proc 80:1187–1200
Winkelstein JA, Marino MC, Ochs H et al (2003) The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 82: 373–384
Wolach B, Eliakim A, Pomeranz A et al (1996) Cyclosporin treatment of hyperimmunoglobulin E syndrome. Lancet 347:67
Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D et al (2006) Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol 97:257–261
Zuraw BL (2005) Current and future therapy for hereditary angioedema. Clin Immunol 114:10–16
Zuraw BL (2006) Novel therapies for hereditary angioe-dema. Immunol Allergy Clin North Am 26:691–708
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Micali, G., West, D.P., Paller, A.S. (2010). Immunodeficiency Disorders. In: Krieg, T., Bickers, D.R., Miyachi, Y. (eds) Therapy of Skin Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78814-0_51
Download citation
DOI: https://doi.org/10.1007/978-3-540-78814-0_51
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78813-3
Online ISBN: 978-3-540-78814-0
eBook Packages: MedicineMedicine (R0)